ERBB2 and breast carcinoma: After skin cancer, breast cancer is the most common cancer in women (18). HER2 (Human Epidermal Growth Factor Receptor 2) or also known as ERBB2 or EGFR2, is one of the well-known oncogenes in breast cancer, and is over expressed in about 30% of breast cancers.